Abstract A071: Non-clinical study of ASP4396, a novel KRAS G12D degrader, shows remarkable anti-tumor activity in KRAS G12D mutant cancer models
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Kanako Iguchi, Kohei Inamura, Mamoru Tasaki, Asuka Saito, Chikako Sato, Ayako Nakayama, Yutaro Ono, Masatoshi Yuri, Tomohiro Yoshinari, Takeyuki Nagashima
Institution: Astellas Pharma (Japan)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7093350659